Table 1.
Patient demographics.
| Characteristic |
All |
2001–2005 |
2006–2010 |
2011–2015 |
P-value |
|---|---|---|---|---|---|
| Number | N = 2647 | n = 716 | n = 994 | n = 937 | |
| Cancer type | 0.001 | ||||
| Cervical | 1194 (45.1%) | 347 (48.5%) | 437 (44.0%) | 410 (43.8%) | |
| Uterine | 394 (14.9%) | 87 (12.2%) | 163 (16.4%) | 144 (15.4%) | |
| Vaginal | 729 (27.6%) | 211 (29.5%) | 282 (28.4%) | 236 (25.2%) | |
| Vulvar | 328 (12.4%) | 70 (9.8%) | 112 (11.3%) | 146 (15.6%) | |
| Age (yr) | 56 (IQR 47–66) | 56 (IQR 46–65) | 56(48–65) | 56 (47–66) | 0.45 |
| <50 | 792 (29.9%) | 226 (31.6%) | 284 (28.6%) | 282 (30.1%) | |
| 50–69 | 1411 (53.3%) | 354 (49.4%) | 543 (54.6%) | 514 (54.9%) | |
| ≥70 | 444 (16.8%) | 136 (19.0%) | 167 (16.8%) | 141 (15.0%) | |
| Race/ethnicity | <0.001 | ||||
| White | 1661 (62.8%) | 433 (60.5%) | 614(61.8%) | 614 (65.6%) | |
| Black | 233 (8.8%) | 38 (5.3%) | 67 (6.7%) | 128 (13.7%) | |
| Hispanic | 214 (8.1%) | 22 (3.1%) | 107 (10.8%) | 85 (9.1%) | |
| Others | 142 (5.4%) | 45 (6.3%) | 47 (4.7%) | 50 (5.3%) | |
| Missing | 396 (15.0%) | 178 (24.9%) | 159 (16.0%) | 59 (6.3%) | |
| Obesity | <0.001 | ||||
| No | 2343 (88.5%) | 684 (95.5%) | 904 (90.9%) | 755 (80.6%) | |
| Yes | 304 (11.5%) | 32 (4.5%) | 90 (9.1%) | 182 (19.4%) | |
| Charlson Index | <0.001 | ||||
| 0 | 1076 (40.7%) | 315 (44.0%) | 426 (42.9%) | 336 (35.8%) | |
| 1 | 562 (21.2%) | 181 (25.3%) | 184(18.5%) | 197 (21.0%) | |
| 2 | 296 (11.2%) | 53 (7.4%) | 151 (15.2%) | 93 (9.9%) | |
| 3–5 | 262 (9.9%) | 38 (5.3%) | 60 (6.0%) | 164(17.5%) | |
| ≥6 | 450 (17.0%) | 129 (18.0%) | 173 (17.4%) | 148 (15.8%) | |
| Median household income | <0.001 | ||||
| ≤$38,999 | 565 (21.4%) | 112 (15.6%) | 269 (27.1%) | 184 (19.7%) | |
| $39,000–$47,999 | 677 (25.6%) | 184 (25.7%) | 232 (23.3%) | 261 (27.9%) | |
| $48,000–$62,999 | 711 (26.9%) | 192 (26.8%) | 258 (26.0%) | 261 (27.9%) | |
| ≥$63,000 | 573 (21.7%) | 201 (28.1%) | 192 (19.3%) | 180 (19.2%) | |
| Missing | 120 (4.5%) | 27 (3.8%) | 43 (4.3%) | 50 (5.3%) | |
| Primary expected payer | <0.001 | ||||
| Medicare | 777 (29.4%) | 205 (28.6%) | 262 (26.4%) | 310 (33.1%) | |
| Medicaid | 578 (21.8%) | 130 (18.2%) | 236 (23.8%) | 212 (22.6%) | |
| Private including HMO | 1096 (41.4%) | 359 (50.1%) | 381 (38.4%) | 356 (38.0%) | |
| Others/missing | 195 (7.4%) | 22 (3.1%) | 114(11.5%) | 59 (6.3%) | |
| Hospital bedsize | ** | ||||
| Small | 207 (7.8%) | 62 (8.7%) | 70 (7.0%) | 75 (8.0%) | |
| Medium | 447 (16.9%) | 138 (19.3%) | 136 (13.7%) | 173 (18.5%) | |
| Large | 1977 (74.7%) | 516 (72.1%) | 783 (78.8%) | 678 (72.4%) | |
| Missing | 16 (0.6%) | * | * | 11 (1.2%) | |
| Hospital teaching status | ** | ||||
| Rural | 14 (0.5%) | * | * | * | |
| Urban non-teaching | 331 (12.5%) | 116 (16.2%) | 112 (11.3%) | 103 (11.0%) | |
| Urban teaching | 2286 (86.4%) | 590 (82.4%) | 873 (87.8%) | 823 (87.8%) | |
| Missing | 16 (0.6%) | * | * | 11 (1.2%) | |
| Hospital region | <0.001 | ||||
| Northeast | 385 (14.6%) | 81 (11.3%) | 152 (15.3%) | 152 (16.2%) | |
| Midwest | 535 (20.2%) | 183 (25.6%) | 170 (17.1%) | 182 (19.4%) | |
| South | 969 (36.6%) | 283 (39.6%) | 381 (38.3%) | 305 (32.6%) | |
| West | 757 (28.6%) | 168 (23.5%) | 291 (29.3%) | 298 (31.8%) |
Median (IQR) or number (percent per column) is shown. Kruskal-Wallis H test or chi-square test for P-values. Significant P-values are emboldened.
*
indicated number of ≤10, required to suppress per the Healthcare Cost and Utilization Project.
**
not assessed due to suppressed number.